DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Bangladesh
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
ACTIVEFINE logo

Active Fine Chemicals Limited Stock Price

DSE:ACTIVEFINE Community·৳1.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

ACTIVEFINE Share Price Performance

৳5.60
-2.70 (-32.53%)
​
৳5.60
-2.70 (-32.53%)
​
Price ৳5.60
Sun, 20 Sep 26
Share Pricen/a

ACTIVEFINE Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Very low risk with weak fundamentals.

2 Risks
0 Rewards
View Full Analysis

Active Fine Chemicals Limited Key Details

৳1.4b

Revenue

৳1.0b

Cost of Revenue

৳336.6m

Gross Profit

৳341.1m

Other Expenses

-৳4.5m

Earnings

Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About ACTIVEFINE

Founded
2004
Employees
n/a
CEO
S. M. Rahman
WebsiteView website
www.afchem.com

Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hydrochloride for anti-bacterial therapeutics. It also offers cefixime trihydrates and cefuroxime axetil for cephalosporin-antibiotics; metformin hydrochloride, sitagliptin phosphate monohydrate, vildagliptin, linagliptin, gliclizide, and glimepiride for anti-diabetic; pregabalin for anti-epileptic; paracetamol for analgesic and antipyrotic; losartan potassium and amlodipine besylate for anti-hypertensive; calcium orotate for use in calcium-supplement; sofosbuvir for anti-hepatitis-C; etoricoxib and ketorolac tromethamine for NSAID; and ticagrelor and amlodipine besylate for anti-platelet therapeutic areas, as well as solvents and powder reagents. Active Fine Chemicals Limited was incorporated in 2004 and is based in Dhaka, Bangladesh.

Recent ACTIVEFINE News & Updates

Recent updates

No updates

Active Fine Chemicals Limited Competitors

SQURPHARMA logo

Square Pharmaceuticals

Symbol: DSE:SQURPHARMA
Market cap: ৳189.5b
BXPHARMA logo

Beximco Pharmaceuticals

Symbol: DSE:BXPHARMA
Market cap: ৳65.7b
RENATA logo

Renata

Symbol: DSE:RENATA
Market cap: ৳51.9b
BEACONPHAR logo

Beacon Pharmaceuticals

Symbol: DSE:BEACONPHAR
Market cap: ৳23.0b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide